A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

Share on Pinterest A new clinical trial examined the effects of an immunotherapy drug on treating dMMR cancers in their early stages and showed remarkable results. Getty Images A new clinical ...

The results from an ambitious cancer study are giving hope that immunotherapy drugs alone can treat some gastrointestinal tumors, eliminating the need for severe, life-altering surgeries and other ...

They were given an immunotherapy drug that overrides how the body allows the immune system to block cancer treatments. No other drugs, except for the immunotherapy treatment, dostarlimab ...

The research was simultaneously published in The New England Journal of Medicine. Immunotherapy drugs work by teaching a person’s immune system to recognize and attack cancer cells. The drugs ...

The trial participants were among the 2 to 3 percent of cancer patients with tumors that should respond to immunotherapy, a drug that overcomes barriers that prevent the immune system from ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

A new clinical trial shows the immunotherapy drug dostarlimab could eliminate the need for surgery and chemotherapy in certain cancers. The results are a medical breakthrough since the drug could ...